Spasov and Bratanov has advised Impetus Capital AD, through the investment fund ImVenture II KDA, on its equity investment in the start-up company Noesis. While the Covid pandemic came as a storm to the world economic, it also brought new opportunities for the pharmaceutical and cosmetic companies and Noesis did not miss its chance to grow and establish a name for itself during this difficult time. In addition with the corporate work related to the acquisition, Impetus also trusted us with the structuring of the financing for Noesis through a series of convertible loans and the all-around legal service in connection with the transaction. The partner Boyko Bratanov and the associates Vladimir Tashev and Krasimir Mitkov, working closely with the client, yet again accomplished great results.

Date: November 2022
Source: Spasov & Bratanov Lawyers’ Partnership

More Posts

THE EU AI ACT: KEY OBLIGATIONS TAKING EFFECT AS OF AUGUST 2ND 2026   Introduction Recognizing both the opportunities and the risks associated with the rapid development of artificial intelligence

Read More »

Spasov & Bratanov successfuly defended the right of a managing director to request his own deletion from the Commercial Register Spasov & Bratanov successfully advised and represented an individual in

Read More »

Welcoming Veronika Stefanova to Spasov & Bratanov We are delighted to welcome Veronika Stefanova to our team as an Associate. Veronika graduated magna cum laude from Sofia University “St. Kliment

Read More »

Successful Resolution of a 19-Year Corporate Dispute Our firm has successfully assisted an individual who is a shareholder and the managing director of a company that holds shares in another

Read More »

Share: